Potential Breakthrough Treatment for Alzheimer’s Could Halt Disease Progression

Scientists at Northwestern University discovered a novel compound, NU-9, that can target a previously unknown brain protein subtype associated with early Alzheimer's disease in mice, potentially allowing for preventative treatment similar to managing high cholesterol. The compound reduces toxic protein accumulation and brain inflammation, paving the way for future research into its effectiveness in later disease stages and its potential to control Alzheimer's before symptoms appear.